
Researchers have restored hand movement and the sense of touch to a man paralysed from the chest down. The results, published in Nature Medicine, suggest the technology partly rewired his nervous system. The system, called a “double neural bypass,” com…

The hard part of medical AI was never the model. It was getting a hospital to actually run it. Bunkerhill Health has raised fresh money to close that gap. The startup closed a $25m Series B led by Khosla Ventures, it told Fortune in an exclusive. That …

One of the minds behind Apple’s Face ID wants to point AI at something harder than a face. He wants it to read the brain. His startup, Hemispheric, has come out of stealth with $52M. The Tel Aviv firm calls itself a NeuroAI company, and its pitch is si…

No name. No product. No confirmed funding. And, possibly, a $2bn price tag. That is the shape of the newest bet in AI drug discovery. Miles Wang, a researcher at OpenAI, is leaving to start his own company, TechCrunch reported. He is in talks to raise …

Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fast-rising star. Chai Discovery has raised a $400m Serie…

Zipline said the number of businesses offering delivery through its app grew 13 times during the first half of 2026. The autonomous drone delivery company has now completed more than 2.5 million commercial deliveries, including one million in the last …

The pitch for medical AI is that it frees clinicians to care for patients. Two stories this week suggest the reality can run the other way. In New York, nurses say software replaced them. In Minnesota, a former Mayo Clinic leader says the software was …